TONGHUA GOLDEN-HORSE
000766Overview
TONGHUA GOLDEN-HORSE (000766)
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceuti...
- Open
- 15.06
- High
- 16.50
- Low
- 14.91
- Prev. Close
- 15.00
- Volume
- 501.62K
- Turnover
- 809.54M
- Avg Price
- 16.14
- Bid/Ask Ratio
- --
- Amplitude
- 10.60%
- 52wk High
- 30.20
- Volume Ratio
- 0.00
- Turnover Ratio
- 5.19%
- 52wk Low
- 13.52
- Float Mkt Cap
- 15.94B
- Market CapCNY
- 15.95B
- P/ETTM
- 1,411.85
- P/EDynamic
- 6,064.52
- P/EStatic
- --
- EPSTTM
- 0.0117
- EPSDynamic
- 0.0027
- EPSStatic
- --
- BVPS
- 2.39
- P/B
- 6.90
- Circulating Supply
- 966.17M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 966.49M
- Min lot size
- 100
- Currency
- CNY
TONGHUA GOLDEN-HORSE Analyst Rating
View moreForecast & Rating
Jun 26, 2018- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView ·
Key facts: EU EV Registrations Reach 22.6%; BMW Shares Dip 0.6%
- Zhitong ·
TONGHUA GOLDEN-HORSE released its performance for the first half of the year, with a net profit attributable to the parent company of 16.804 million yuan, a year-on-year increase of 34.77%
- Zhitong ·
The chemical pharmaceutical sector has declined in the short term, with CSBIO falling over 12%
- Zhitong ·
TONGHUA GOLDEN-HORSE: There are no significant matters that should be disclosed but have not been disclosed
- Zhitong ·
Innovative drug concept stocks rise, Staidson BioPharm up over 10%
- Zhitong ·
TONGHUA GOLDEN-HORSE released its first-quarter performance, with a net profit attributable to the parent company of 11.5828 million yuan, a year-on-year increase of 26.09%
